Glioblastoma Archive - IOZK

Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022

2023-01-31/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-01-31 / Expert Opin Drug Discov 2023 Jan;

[Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma]

2023-01-20/in Dendritic Cells, Glioblastoma, International Publications /von 2023-01-20 / Strahlenther Onkol 2023 Jan;

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

2023-01-01/in Dendritic Cells, Glioblastoma, International Publications /von 2023-01-01 / JAMA Oncol 2023 Jan;9(1):112-121

Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?

2022-12-23/in Dendritic Cells, Glioblastoma, International Publications /von 2022-12-23 / Neuro Oncol 2022 Dec;

Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions

2022-12-04/in Dendritic Cells, Glioblastoma, International Publications /von 2022-12-04 / Cancer Med 2022 Dec;

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy

2022-09-06/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2022-09-06 / Molecules 2022 Sep;27(18)

Poster presentation at the annual meeting of the Association for Cancer Immunotherapy

2022-06-02/in Glioblastoma, International Publications, IOZK bei Fachtagungen, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)

Poster presentation at the International Symposium on Pediatric Neuro-Oncology

2022-06-02/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)

A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis

2022-03-08/in Dendritic Cells, Glioblastoma, International Publications /von 2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-531

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

2022-02-16/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;